Corallium rubrum Švajčiarsko - nemčina - Swissmedic (Swiss Agency for Therapeutic Products)

corallium rubrum

shi homöopathie ag - corallium in rot - tm, d; tm, t; lm/q1, d; k30, d - homöopathisch

Corallium rubrum ext. Švajčiarsko - nemčina - Swissmedic (Swiss Agency for Therapeutic Products)

corallium rubrum ext.

boiron sa - corallium in rot - d1, d, c1, d - homöopathisch

Corallium rubrum gg Švajčiarsko - nemčina - Swissmedic (Swiss Agency for Therapeutic Products)

corallium rubrum gg

boiron sa - corallium in rot - tm, d; lm/q1, d; k30, d; tm, d - homöopathisch

Corallium rubrum supp. Švajčiarsko - nemčina - Swissmedic (Swiss Agency for Therapeutic Products)

corallium rubrum supp.

boiron sa - corallium in rot - c1, d, d1, d - homöopathisch

Corallium rubrum; Trit Švajčiarsko - nemčina - Swissmedic (Swiss Agency for Therapeutic Products)

corallium rubrum; trit

weleda ag - corallium in rot - trituration / pulver - d1, d - anthroposophisch

Corallium rubrum plus Švajčiarsko - nemčina - Swissmedic (Swiss Agency for Therapeutic Products)

corallium rubrum plus

hans rentsch ag - natrium tetraboracicum, d18, 10.0 mg / 1 gramm; corallium rot, d6 10,0 mg / 1 gramm; corallium rot, d18, 10.0 mg / 1 gramm; natrium tetraboracicum, d30, 10.0 mg / 1 gramm; natrium tetraboracicum, d8, 10.0 mg / 1 gramm; aus eisen arsenicosum, d18, 10.0 mg / 1 gramm; corallium rot, d24, 10.0 mg / 1 gramm; aus eisen arsenicosum, d30, 10.0 mg / 1 gramm; aus eisen arsenicosum, d8, 10.0 mg / 1 gramm - d - corallium rubrum, d18, 10.0 mg / 1 gramm; natrium tetraboracicum, d18, 10.0 mg / 1 gramm; corallium rubrum, d6, 10.0 mg / 1 gramm; natrium tetraboracicum, d30, 10.0 mg / 1 gramm; natrium tetraboracicum, d8, 10.0 mg / 1 gramm; ferrum arsenicosum, d18, 10.0 mg / 1 gramm; corallium rubrum, d24, 10.0 mg / 1 gramm; ferrum arsenicosum, d30, 10.0 mg / 1 gramm; ferrum arsenicosum, d8, 10.0 mg / 1 gramm - homöopathisch

Braftovi Európska únia - nemčina - EMA (European Medicines Agency)

braftovi

pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastische mittel - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.

lisinopril-corax comp. 20 mg / 12,5 mg Tabletten Nemecko - nemčina - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

lisinopril-corax comp. 20 mg / 12,5 mg tabletten

corax pharma gmbh (8005020) - lisinopril-dihydrat; hydrochlorothiazid - tablette - teil 1 - tablette; lisinopril-dihydrat (24123) 21,78 milligramm; hydrochlorothiazid (00512) 12,5 milligramm

lisinopril-corax comp. 10 mg / 12,5 mg Tabletten Nemecko - nemčina - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

lisinopril-corax comp. 10 mg / 12,5 mg tabletten

corax pharma gmbh (8005020) - lisinopril-dihydrat; hydrochlorothiazid - tablette - teil 1 - tablette; lisinopril-dihydrat (24123) 10,89 milligramm; hydrochlorothiazid (00512) 12,5 milligramm

metoprolol-corax 200mg retard Retardtabletten Nemecko - nemčina - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

metoprolol-corax 200mg retard retardtabletten

corax pharma gmbh (8005020) - metoprololtartrat (ph.eur.) - retardtablette - teil 1 - retardtablette; metoprololtartrat (ph.eur.) (11849) 200 milligramm